These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30731190)

  • 1. Structural basis for isoniazid resistance in KatG double mutants of Mycobacterium tuberculosis.
    Rabha A; Singh A; Grover S; Kumari A; Pandey B; Grover A
    Microb Pathog; 2019 Apr; 129():152-160. PubMed ID: 30731190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular investigation of active binding site of isoniazid (INH) and insight into resistance mechanism of S315T-MtKatG in Mycobacterium tuberculosis.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Tuberculosis (Edinb); 2017 Jul; 105():18-27. PubMed ID: 28610784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.
    Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.
    Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP
    J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
    Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
    Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
    Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
    Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
    Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
    Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
    Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
    J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
    Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
    Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.
    Pimentel AL; de Lima Scodro RB; Caleffi-Ferracioli KR; Siqueira VL; Campanerut-Sá PA; Lopes LD; de Almeida AL; Cardoso RF; Seixas FA
    J Mol Model; 2017 Apr; 23(4):121. PubMed ID: 28303436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.
    Purohit R; Rajendran V; Sethumadhavan R
    J Mol Model; 2011 Apr; 17(4):869-77. PubMed ID: 20593210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
    Yu S; Girotto S; Lee C; Magliozzo RS
    J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on the Mechanism of Action of INH-C
    Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
    Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Analysis of
    Purkan P; Ihsanawati I; Natalia D; Syah YM; Retnoningrum DS; Siswanto I
    J Med Life; 2018; 11(2):160-167. PubMed ID: 30140323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.
    Mo L; Zhang W; Wang J; Weng XH; Chen S; Shao LY; Pang MY; Chen ZW
    Microb Drug Resist; 2004; 10(4):269-79. PubMed ID: 15650370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
    Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
    Yıldırım E; Uzun M
    Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.